Trial Outcomes & Findings for Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture (NCT NCT01878383)
NCT ID: NCT01878383
Last Updated: 2020-09-09
Results Overview
Assessing the vaginal specimen collected via a swab of non-pregnant women presenting to their provider at the time of active HSV outbreak with standard HSV culture compared to the assay of new device called a GeneXpert. Percent of GeneXpert assessment in agreement with standard HSV culture, for subjects who were positive for HSV according to culture.
COMPLETED
12550 participants
on day of enrollment
2020-09-09
Participant Flow
Participant milestones
| Measure |
Non-pregnant Women/Active HSV Lesions
Women presenting to local health department
Genexpert assay
|
Pregnant Women/no Active HSV Lesions
Women presenting in active labor will be tested for HSV utilizing the Genexpert assay
|
|---|---|---|
|
Overall Study
STARTED
|
50
|
12500
|
|
Overall Study
COMPLETED
|
50
|
11001
|
|
Overall Study
NOT COMPLETED
|
0
|
1499
|
Reasons for withdrawal
| Measure |
Non-pregnant Women/Active HSV Lesions
Women presenting to local health department
Genexpert assay
|
Pregnant Women/no Active HSV Lesions
Women presenting in active labor will be tested for HSV utilizing the Genexpert assay
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
0
|
1499
|
Baseline Characteristics
Age was not collected
Baseline characteristics by cohort
| Measure |
Non-pregnant Women/Active HSV Lesions
n=50 Participants
Women presenting to local health department
Genexpert assay
|
Pregnant Women/no Active HSV Lesions
n=12500 Participants
Women presenting in active labor
Genexpert assay
|
Total
n=12550 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Sex: Female, Male
Female
|
50 Participants
n=50 Participants
|
12500 Participants
n=12500 Participants
|
12550 Participants
n=12550 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=50 Participants
|
0 Participants
n=12500 Participants
|
0 Participants
n=12550 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=50 Participants • Baseline information not available for 2 subjects
|
1090 Participants
n=12498 Participants • Baseline information not available for 2 subjects
|
1091 Participants
n=12548 Participants • Baseline information not available for 2 subjects
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
49 Participants
n=50 Participants • Baseline information not available for 2 subjects
|
11124 Participants
n=12498 Participants • Baseline information not available for 2 subjects
|
11173 Participants
n=12548 Participants • Baseline information not available for 2 subjects
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=50 Participants • Baseline information not available for 2 subjects
|
284 Participants
n=12498 Participants • Baseline information not available for 2 subjects
|
284 Participants
n=12548 Participants • Baseline information not available for 2 subjects
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=50 Participants • Demographic information not available for 2 subjects.
|
39 Participants
n=12498 Participants • Demographic information not available for 2 subjects.
|
39 Participants
n=12548 Participants • Demographic information not available for 2 subjects.
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=50 Participants • Demographic information not available for 2 subjects.
|
335 Participants
n=12498 Participants • Demographic information not available for 2 subjects.
|
335 Participants
n=12548 Participants • Demographic information not available for 2 subjects.
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=50 Participants • Demographic information not available for 2 subjects.
|
23 Participants
n=12498 Participants • Demographic information not available for 2 subjects.
|
23 Participants
n=12548 Participants • Demographic information not available for 2 subjects.
|
|
Race (NIH/OMB)
Black or African American
|
43 Participants
n=50 Participants • Demographic information not available for 2 subjects.
|
4631 Participants
n=12498 Participants • Demographic information not available for 2 subjects.
|
4674 Participants
n=12548 Participants • Demographic information not available for 2 subjects.
|
|
Race (NIH/OMB)
White
|
7 Participants
n=50 Participants • Demographic information not available for 2 subjects.
|
6859 Participants
n=12498 Participants • Demographic information not available for 2 subjects.
|
6866 Participants
n=12548 Participants • Demographic information not available for 2 subjects.
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=50 Participants • Demographic information not available for 2 subjects.
|
225 Participants
n=12498 Participants • Demographic information not available for 2 subjects.
|
225 Participants
n=12548 Participants • Demographic information not available for 2 subjects.
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=50 Participants • Demographic information not available for 2 subjects.
|
386 Participants
n=12498 Participants • Demographic information not available for 2 subjects.
|
386 Participants
n=12548 Participants • Demographic information not available for 2 subjects.
|
PRIMARY outcome
Timeframe: on day of enrollmentAssessing the vaginal specimen collected via a swab of non-pregnant women presenting to their provider at the time of active HSV outbreak with standard HSV culture compared to the assay of new device called a GeneXpert. Percent of GeneXpert assessment in agreement with standard HSV culture, for subjects who were positive for HSV according to culture.
Outcome measures
| Measure |
Non-pregnant Women/Active HSV Lesions
n=50 Participants
Women presenting to local health department
Genexpert assay
|
|---|---|
|
Sensitivity of Detection of HSV DNA by GeneXpert PCR From Specimens Obtained From the Genital Tract of Non-pregnant Women in STI Clinics, as Compared With HSV Culture
|
100 Sensitivity (percent positive)
Interval 90.8 to 100.0
|
PRIMARY outcome
Timeframe: DAY OF ENROLLMENTPopulation: 12,500 pregnant women were enrolled into this study and were randomized (1:1) to either have their specimens stored or tested. The analysis population is the 6,658 subjects randomized to the test condition
Detection of HSV DNA by GeneXpert PCR compared to routine PCR detection by viral DNA. Percent of GeneXpert assessment in agreement with routine PCR detection, for subjects who are positive for HSV according to routine PCR.
Outcome measures
| Measure |
Non-pregnant Women/Active HSV Lesions
n=6658 Participants
Women presenting to local health department
Genexpert assay
|
|---|---|
|
Positive Percent Agreement of Detection of HSV DNA by GeneXpert PCR From Specimens Obtained From Genital Tract of Pregnant Women, as Compared With Routine PCR Detection of Viral DNA
|
80 Positive percent agreement
Interval 73.7 to 86.3
|
PRIMARY outcome
Timeframe: DAY OF ENROLLMENTPopulation: 12,500 pregnant women were enrolled into this study and were randomized (1:1) to either have the specimens stored or tested. The analysis population is the 6,658 subjects randomized to the test condition
Detection of HSV DNA by GeneXpert PCR compared to routine PCR detection by viral DNA. Percent of GeneXpert assessments in agreement with routine PCR detection, for subjects who were negative for HSV according to routine PCR.
Outcome measures
| Measure |
Non-pregnant Women/Active HSV Lesions
n=6658 Participants
Women presenting to local health department
Genexpert assay
|
|---|---|
|
Negative Percent Agreement of Detection of HSV DNA by GeneXpert PCR From Specimens Obtained From Genital Tract of Pregnant Women, as Compared With Routine PCR Detection of Viral DNA
|
99.2 Negative percent agreement
Interval 99.0 to 99.5
|
Adverse Events
Non-pregnant Women/Active HSV Lesions
Pregnant Women/no Active HSV Lesions
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
David Kimberlin, MD
University of Alabama at Birmingham
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place